Skip to main content
. 2024 Dec 24;24:490. doi: 10.1186/s12883-024-03990-9

Table 2.

Baseline test score table

Outcome measures Study (Patient) SMD(95%CI) P-value of the intervention effect Heterogeneity
Cognitive function MOCA 3(n = 175) 0.103,(-0.195;0.401) P = 0.496 I2 = 0%, P = 0.544
Depressive symptoms HAMD 4(n = 168) 0.071,(-0.219;0.362) P = 0.631 I2 = 2.6%, P = 0.392
Walk ability FOG-Q 3(n = 90) 0.023,(-0.398;0.444) P = 0.915 I2 = 0%, P = 0.967
TUGT 5(n = 178) -0.182,(-0.470; 0.106) P = 0.216 I2 = 4%, P = 0.108;
UPDRSIII 11(n = 489) -0.03,(-0.203;0.142) P = 0.730 I2 = 0%, P = 0.993